Skip to main content
Equibles

BLAIR WILLIAM & CO/IL

Position in GALT — Galectin Therapeutics Inc

CIK 902367 CHICAGO, IL
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$692,673
+$276,174 QoQ
Shares Held
149,283
0.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 98 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BLAIR WILLIAM & CO/IL holds $184,064,705 across 61 Biotechnology names. GALT ranks #27 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 513,573 $36,283,932
2 TWST
Twist Bioscience Corp
 256,556 $26,394,481
3 ARGX
Argenx SE
 27,666 $25,667,684
4 VKTX
Viking Therapeutics, Inc.
 416,766 $16,258,041
5 EXEL
Exelixis, Inc.
 243,215 $13,233,328
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,400 $9,139,832
7 SLDB
Solid Biosciences Inc.
 756,277 $7,555,207
8 AXSM
Axsome Therapeutics, Inc.
 23,450 $5,739,856

All Filings in GALT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $692,673 149,283
2026-03-31 $416,499 149,283
2025-12-31 $157,597 37,884
2025-09-30 $160,628 37,884
2025-06-30 $79,935 37,884
2025-03-31 $46,218 37,884
2024-12-31 $48,870 37,884
2024-09-30 $104,181 37,884
2024-06-30 $85,617 37,884
2024-03-31 $90,542 37,884
2023-12-31 $62,887 37,884
2023-09-30 $72,737 37,884
2023-06-30 $54,552 37,884
2023-03-31 $79,556 37,884
2022-12-31 $42,808 37,884
2022-09-30 $66,640 40,884
2022-06-30 $53,558 40,884
2021-09-30 $41,733 10,756
2021-06-30 $34,419 10,756
2021-03-31 $23,340 10,756
2020-12-31 $24,093 10,756
2020-09-30 $28,718 10,756
2020-06-30 $32,913 10,756
2020-03-31 $21,081 10,756